| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |